The regulation of MFG‐E8 on the mitophagy in diabetic sarcopenia via the HSPA1L‐Parkin pathway and the effect of D‐pinitol
Journal of Cachexia, Sarcopenia and Muscle · 2024
DOI: 10.1002/jcsm.13459 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2024. Verfasst von Wenqian Zhao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Mitophagy, Sarcopenia, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Youth Fund Project of National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Special Project for Basic Work of Projects of the Ministry of Science and Technology.
Abstract (Originalsprache)
Background
Diabetic sarcopenia is a disease‐related skeletal muscle disorder that causes progressive symptoms. The complete understanding of its pathogenesis is yet to be unravelled, which makes it difficult to develop effective therapeutic strategies. This study investigates how MFG‐E8 affects mitophagy and the protective role of D‐pinitol (DP) in diabetic sarcopenia.
Methods
In vivo, streptozotocin‐induced diabetic SAM‐R1 (STZ‐R1) and SAM‐P8 (STZ‐P8) mice (16‐week‐old) were used, and STZ‐P8 mice were administrated of DP (150 mg/kg per day) for 6 weeks. Gastrocnemius muscles were harvested for histological analysis including transmission electron microscopy. Proteins were evaluated via immunohistochemistry (IHC), immunofluorescence (IF), and western blotting (WB) assay. In vitro, advanced glycation end products (AGEs) induced diabetic and D‐galactose (DG) induced senescent C2C12 models were established and received DP, MFG‐E8 plasmid (Mover)/siRNA (MsiRNA), or 3‐MA/Torin‐1 intervention. Proteins were evaluated by IF and WB assay. Immunoprecipitation (IP) and co‐immunoprecipitation (CO‐IP) were used for hunting the interacted proteins of MFG‐E8.
Results
In vivo, sarcopenia, mitophagy deficiency, and up‐regulated MFG‐E8 were confirmed in the STZ‐P8 group. DP exerted protective effects on sarcopenia and mitophagy (DP + STZ‐P8 vs. STZ‐P8; all P < 0.01), such as increased lean mass (8.47 ± 0.81 g vs. 7.08 ± 1.64 g), grip strength (208.62 ± 39.45 g vs. 160.87 ± 26.95 g), rotarod tests (109.7 ± 11.81 s vs. 59.3 ± 20.97 s), muscle cross‐sectional area (CSA) (1912.17 ± 535.61 μm 2 vs. 1557.19 ± 588.38 μm 2 ), autophagosomes (0.07 ± 0.02 per μm 2 vs. 0.02 ± 0.01 per μm 2 ), and cytolysosome (0.07 ± 0.03 per μm 2 vs. 0.03 ± 0.01 per μm 2 ). DP down‐regulated MFG‐E8 in both serum (DP + STZ‐P8: 253.19 ± 34.75 pg/mL vs. STZ‐P8: 404.69 ± 78.97 pg/mL; P < 0.001) and gastrocnemius muscle (WB assay. DP + STZ‐P8: 0.39 ± 0.04 vs. STZ‐P8: 0.55 ± 0.08; P < 0.01). DP also up‐regulated PINK1, Parkin and LC3B‐II/I ratio, and down‐regulated P62 in gastrocnemius muscles (all P < 0.01). In vitro, mitophagy deficiency and MFG‐E8 up‐regulation were confirmed in diabetic and senescent models (all P < 0.05). DP and MsiRNA down‐regulated MFG‐E8 and P62, and up‐regulated PINK1, Parkin and LC3B‐II/I ratio to promote mitophagy as Torin‐1 does (all P < 0.05). HSPA1L was confirmed as an interacted protein of MFG‐E8 in IP and CO‐IP assay. Mover down‐regulated the expression of Parkin via the HSPA1L‐Parkin pathway, leading to mitophagy inhibition. MsiRNA up‐regulated the expression of PINK1 via SGK1, FOXO1, and STAT3 phosphorylation pathways, leading to mitophagy stimulation.
Conclusions
MFG‐E8 is a crucial target protein of DP and plays a distinct role in mitophagy regulation. DP down‐regulates the expression of MFG‐E8, reduces mitophagy deficiency, and alleviates the symptoms of diabetic sarcopenia, which could be considered a novel therapeutic strategy for diabetic sarcopenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatric Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Key Laboratory of Cardiovascular Proteomics of Shandong Province, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
- Jinan Clinical Research Center for Geriatric Medicine (202132001), Jinan, China.
- Postdoctoral Research Station, Shandong University of Traditional Chinese Medicine, Jinan, China.
- Health Management Center (East Area), Qilu Hospital of Shandong University, Jinan, China.
- Department of Pharmacy, Qilu Hospital of Shandong University, Jinan, China.
ORCID-Profile: Mei Cheng
Förderung
- Youth Fund Project of National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Special Project for Basic Work of Projects of the Ministry of Science and Technology
- Major Special Projects of the Ministry of Science and Technology
- Scientific and Technological Key Projects of Shandong Province
- National Outstanding Youth Science Fund Project of National Natural Science Foundation of China
Zitieren
APA
Zhao, W., Zhao, B., Meng, X., Li, B., Wang, Y., Yu, F., Fu, C., Yu, X., Li, X., Dai, C., Wang, J., Gao, H., & Cheng, M. (2024). The regulation of MFG‐E8 on the mitophagy in diabetic sarcopenia via the HSPA1L‐Parkin pathway and the effect of D‐pinitol. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.13459
Vancouver
Zhao W, Zhao B, Meng X, Li B, Wang Y, Yu F, et al. The regulation of MFG‐E8 on the mitophagy in diabetic sarcopenia via the HSPA1L‐Parkin pathway and the effect of D‐pinitol. Journal of Cachexia, Sarcopenia and Muscle. 2024. doi:10.1002/jcsm.13459
BibTeX
@article{Zhao2024,
author = {Zhao, Wenqian and Zhao, Bin and Meng, Xinyue and Li, Baoying and Wang, Yajuan and Yu, Fei and Fu, Chunli and Yu, Xin and Li, Xiaoli and Dai, Chaochao and Wang, Jie and Gao, Haiqing and Cheng, Mei},
title = {The regulation of MFG‐E8 on the mitophagy in diabetic sarcopenia via the HSPA1L‐Parkin pathway and the effect of D‐pinitol},
journal = {Journal of Cachexia, Sarcopenia and Muscle},
year = {2024},
doi = {10.1002/jcsm.13459}
}
EUVIMED